SERUM NON-HDL CHOLESTEROL TO APOLIPOPROTEIN B RATIO AS A SCREENING TEST FOR FAMILIAL DYSBETALIPOPROTEINAEMIA (TYPE III HYPERLIPIDAEMIA) IN PATIENTS WITH MIXED HYPERLIPIDAEMIA

被引：0
|
作者：
Boot, Christopher [1 ]
Holmes, Elizabeth [1 ]
Neely, R. Dermot G. [1 ]
机构：
[1] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Blood Sci, Suprareg Assay Serv Cardiovasc Biomarkers, Newcastle Upon Tyne, Tyne & Wear, England
来源：
ATHEROSCLEROSIS | 2016年 / 255卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4
引用
收藏
页码：E7 / E7
页数：1
相关论文
共 33 条
  • [1] VALIDATION OF SERUM APOB/CHOLESTEROL AND APOB/NON-HDL CHOLESTEROL RATIOS AS SCREENING TESTS FOR TYPE III HYPERLIPIDAEMIA
    Boot, C.
    Holmes, E.
    Neely, D.
    Jenkinson, F.
    Datta, H.
    Hughes, L.
    ATHEROSCLEROSIS, 2016, 252 : E48 - E48
  • [2] Serum remnant lipoprotein cholesterol/triglyceride ratio as an index for screening familial type III hyperlipidaemia
    Nakajima, Katsuyuki
    Daimon, Masahiro
    Kamiyama, Kiyoshi
    Takanashi, Kunihiko
    Suzuki, Yukiko
    Watanabe, Masakazu
    Kubono, Katsuo
    Saniabadi, Abby R.
    Takashima, Sei-Ichi
    Sakurabayashi, Ikunosuke
    ANNALS OF CLINICAL BIOCHEMISTRY, 2007, 44 : 353 - 359
  • [3] Evaluation of the Non-HDL Cholesterol to Apolipoprotein B Ratio as a Screening Test for Dysbetalipoproteinemia
    Boot, Christopher S.
    Middling, Elizabeth
    Allen, Joy
    Neely, Robert D. G.
    CLINICAL CHEMISTRY, 2019, 65 (02) : 313 - 320
  • [4] NON-HDL CHOLESTEROL/APOLIPOPROTEIN B RATIO IN THE DIAGNOSIS OF DYSBETALIPOPROTEINEMIA
    Bea, A. M.
    Cenarro, A.
    Marco, V.
    Mateo-Gallego, R.
    Jarauta, E.
    Gracia-Rubio, I.
    Laclaustra, M.
    Civeira, F.
    ATHEROSCLEROSIS, 2021, 331 : E214 - E214
  • [5] Non-HDL cholesterol and apolipoprotein B in the dyslipidemic classification of type 2 diabetic patients
    Wägner, AM
    Pérez, A
    Zapico, E
    Ordóñez-Llanos, J
    DIABETES CARE, 2003, 26 (07) : 2048 - 2051
  • [6] Non-HDL-cholesterol/apolipoprotein B ratio: A useful distinguishing feature in the screening for type III hyperlipoproteinemia
    Murase, Toshio
    Okubo, Minoru
    Takeuchi, Ichiro
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (02) : 99 - 104
  • [7] Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes
    Jiang, R
    Schulze, MB
    Li, TC
    Rifal, N
    Stampfer, MJ
    Rimm, EB
    Hu, FB
    DIABETES CARE, 2004, 27 (08) : 1991 - 1997
  • [8] Evaluation of Apo B, Non-HDL Cholesterol Levels and Apo B/Apo A-1 Ratio in Patients with Type 2 Diabetes
    Altinova, Alev Eroglu
    Akturk, Mujde
    Toruner, Fusun
    Cakir, Nuri
    Arslan, Metin
    GAZI MEDICAL JOURNAL, 2013, 24 (03): : 78 - 80
  • [9] Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients
    Johannesen, Camilla Ditlev Lindhardt
    Mortensen, Martin Bodtker
    Langsted, Anne
    Nordestgaard, Borge Gronne
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (11) : 1439 - 1450
  • [10] Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia
    Farnier, Michel
    Guyton, John R.
    Jensen, Erin
    Polis, Adam B.
    Johnson-Levonas, Amy O.
    Brudi, Philippe
    ATHEROSCLEROSIS, 2013, 229 (02) : 415 - 422
1234